203 related articles for article (PubMed ID: 1473965)
21. [Xenotransplantation: physiopathology of hyperacute and differentiated rejection, and therapeutic perspectives].
Malassagne B; Calmus Y; Houssin D; Weill B
Pathol Biol (Paris); 2000 May; 48(4):377-82. PubMed ID: 10868402
[TBL] [Abstract][Full Text] [Related]
22. Transplantation of discordant xenografts: a review of progress.
Platt JL; Vercellotti GM; Dalmasso AP; Matas AJ; Bolman RM; Najarian JS; Bach FH
Immunol Today; 1990 Dec; 11(12):450-6; discussion 456-7. PubMed ID: 2073317
[TBL] [Abstract][Full Text] [Related]
23. The immunological hurdles to cardiac xenotransplantation.
Platt JL
J Card Surg; 2001; 16(6):439-47. PubMed ID: 11925024
[TBL] [Abstract][Full Text] [Related]
24. Prolongation of cardiac xenograft survival by depletion of complement.
Leventhal JR; Dalmasso AP; Cromwell JW; Platt JL; Manivel CJ; Bolman RM; Matas AJ
Transplantation; 1993 Apr; 55(4):857-65; discussion 865-6. PubMed ID: 8475561
[TBL] [Abstract][Full Text] [Related]
25. [Recent advances in xenotransplantation].
Jeffrey L; Platt MD
Presse Med; 1992 Dec; 21(41):1932-8. PubMed ID: 1294943
[TBL] [Abstract][Full Text] [Related]
26. [Xenotransplantation].
Itsuo Y; Shugi H; Takaaki K; Masataka N; Yasushi N; Akiko K; Takaharu N; Taiki K; Chihiro K; Hiroshi T
Nihon Geka Gakkai Zasshi; 1996 Nov; 97(11):1010-7. PubMed ID: 9010858
[TBL] [Abstract][Full Text] [Related]
27. Activation of endothelial cells in hyperacute xenograft rejection.
Geller RL; Bach FH; Vercellotti GM; Nistler RS; Bolman RM; Fischel RJ; Leventhal J; Platt JL
Transplant Proc; 1992 Apr; 24(2):592. PubMed ID: 1566442
[No Abstract] [Full Text] [Related]
28. Functional activity of the membrane-associated complement inhibitor CD59 in a pig-to-human in vitro model for hyperacute xenograft rejection.
Heckl-Ostreicher B; Binder R; Kirschfink M
Clin Exp Immunol; 1995 Dec; 102(3):589-95. PubMed ID: 8536377
[TBL] [Abstract][Full Text] [Related]
29. Sulfonated dextran inhibits complement activation and complement-dependent cytotoxicity in an in vitro model of hyperacute xenograft rejection.
Thomas H; Maillet F; Letourneur D; Jozefonvicz J; Fischer E; Kazatchkine MD
Mol Immunol; 1996; 33(7-8):643-8. PubMed ID: 8760276
[TBL] [Abstract][Full Text] [Related]
30. A human CD46 transgenic pig model system for the study of discordant xenotransplantation.
Diamond LE; Quinn CM; Martin MJ; Lawson J; Platt JL; Logan JS
Transplantation; 2001 Jan; 71(1):132-42. PubMed ID: 11211178
[TBL] [Abstract][Full Text] [Related]
31. Xenotransplantation.
Cozzi E; White DJ
Curr Opin Nephrol Hypertens; 1996 Nov; 5(6):514-8. PubMed ID: 8978999
[TBL] [Abstract][Full Text] [Related]
32. Endothelial cell protection and complement inhibition in xenotransplantation: a novel in vitro model using whole blood.
Banz Y; Cung T; Korchagina EY; Bovin NV; Haeberli A; Rieben R
Xenotransplantation; 2005 Nov; 12(6):434-43. PubMed ID: 16202066
[TBL] [Abstract][Full Text] [Related]
33. Activation of the alternative pathway of complement in hyperacute xenograft rejection of rabbit hearts by human blood.
Forty J; White DJ; Wallwork J
J Heart Lung Transplant; 1993; 12(2):283-6; discussion 286-7. PubMed ID: 8476902
[TBL] [Abstract][Full Text] [Related]
34. Complement regulation in the GalT KO era.
Miyagawa S; Yamamoto A; Matsunami K; Wang D; Takama Y; Ueno T; Okabe M; Nagashima H; Fukuzawa M
Xenotransplantation; 2010; 17(1):11-25. PubMed ID: 20149185
[TBL] [Abstract][Full Text] [Related]
35. Role of complement and perspectives for intervention in transplantation.
Chen G; Chen S; Chen X
Immunobiology; 2013 May; 218(5):817-27. PubMed ID: 23182708
[TBL] [Abstract][Full Text] [Related]
36. Future directions in transplantation: xenotransplantation.
Somerville CA; d'Apice AJ
Kidney Int Suppl; 1993 Jul; 42():S112-21. PubMed ID: 8361121
[TBL] [Abstract][Full Text] [Related]
37. Molecular strategies for clinical xenotransplantation in cardiothoracic surgery.
Hoopes CW; Platt JF
Semin Thorac Cardiovasc Surg; 1996 Apr; 8(2):156-74. PubMed ID: 8672569
[TBL] [Abstract][Full Text] [Related]
38. Human complement activation via the alternative pathway on porcine endothelium initiated by IgA antibodies.
Schaapherder AF; Gooszen HG; te Bulte MT; Daha MR
Transplantation; 1995 Aug; 60(3):287-91. PubMed ID: 7645041
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo studies to prevent hyperacute rejection.
Miyagawa S; Mikata M; Matsuda H; Ikawa M; Okabe M; Nagasawa S; Matsumoto M; Seya T; Shirakura R
Transplant Proc; 1996 Apr; 28(2):1031-3. PubMed ID: 8623217
[No Abstract] [Full Text] [Related]
40. Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.
Magee JC; Collins BH; Harland RC; Lindman BJ; Bollinger RR; Frank MM; Platt JL
J Clin Invest; 1995 Nov; 96(5):2404-12. PubMed ID: 7593628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
